
PMC:7279430 / 0-1141
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 303-310 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T2 | 645-648 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T3 | 659-662 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T4 | 736-743 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 0-14 | Chemical | denotes | Essential Oils | MESH:D009822 |
4 | 49-63 | Chemical | denotes | Essential Oils | MESH:D009822 |
5 | 73-93 | Disease | denotes | SARS-CoV-2 Infection | MESH:C000657245 |
43 | 515-519 | Gene | denotes | Mpro | Gene:8673700 |
44 | 686-690 | Gene | denotes | RdRp | Gene:43740578 |
45 | 730-735 | Gene | denotes | spike | Gene:43740568 |
46 | 771-800 | Gene | denotes | angiotensin−converting enzyme | Gene:1636 |
47 | 802-807 | Gene | denotes | hACE2 | Gene:59272 |
48 | 876-880 | Gene | denotes | Mpro | Gene:8673700 |
49 | 331-378 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
50 | 380-390 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
51 | 478-488 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
52 | 504-514 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
53 | 522-532 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
54 | 552-562 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
55 | 578-588 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
56 | 616-626 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
57 | 634-644 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
58 | 675-685 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
59 | 719-729 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
60 | 745-755 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
61 | 765-770 | Species | denotes | human | Tax:9606 |
62 | 865-875 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
63 | 961-969 | Species | denotes | SARS−CoV | Tax:694009 |
64 | 991-995 | Species | denotes | E)-α | Tax:114629 |
65 | 1097-1107 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
68 | 132-146 | Chemical | denotes | Essential oils | MESH:D009822 |
69 | 256-269 | Chemical | denotes | essential oil | MESH:D009822 |
70 | 889-914 | Chemical | denotes | sesquiterpene hydrocarbon | |
71 | 915-930 | Chemical | denotes | (E)-β-farnesene | |
72 | 1007-1022 | Chemical | denotes | (E)-β-farnesene | |
73 | 1028-1042 | Chemical | denotes | (E,E)−farnesol | |
74 | 1044-1058 | Chemical | denotes | (E,E)−Farnesol |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 73-81 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 84-93 | Disease | denotes | Infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T3 | 331-378 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 331-364 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 380-388 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 478-486 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 504-512 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 522-530 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 552-560 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T10 | 578-586 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 616-624 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T12 | 634-642 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T13 | 675-683 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T14 | 719-727 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T15 | 745-753 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T16 | 865-873 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T17 | 961-965 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T18 | 1097-1105 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 213-220 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T2 | 393-394 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T3 | 756-758 | http://purl.obolibrary.org/obo/CLO_0008882 | denotes | rS |
T4 | 765-770 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 169-185 | Chemical | denotes | antiviral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
T2 | 256-280 | Chemical | denotes | essential oil components | http://purl.obolibrary.org/obo/CHEBI_27311 |
T3 | 256-269 | Chemical | denotes | essential oil | http://purl.obolibrary.org/obo/CHEBI_83630 |
T4 | 303-310 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T5 | 448-472 | Chemical | denotes | essential oil components | http://purl.obolibrary.org/obo/CHEBI_27311 |
T6 | 448-461 | Chemical | denotes | essential oil | http://purl.obolibrary.org/obo/CHEBI_83630 |
T7 | 589-592 | Chemical | denotes | ADP | http://purl.obolibrary.org/obo/CHEBI_16761|http://purl.obolibrary.org/obo/CHEBI_456216|http://purl.obolibrary.org/obo/CHEBI_73342 |
T10 | 593-599 | Chemical | denotes | ribose | http://purl.obolibrary.org/obo/CHEBI_33942|http://purl.obolibrary.org/obo/CHEBI_47013 |
T12 | 736-743 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T13 | 771-782 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T14 | 889-902 | Chemical | denotes | sesquiterpene | http://purl.obolibrary.org/obo/CHEBI_35189 |
T15 | 903-914 | Chemical | denotes | hydrocarbon | http://purl.obolibrary.org/obo/CHEBI_24632 |
T16 | 921-930 | Chemical | denotes | farnesene | http://purl.obolibrary.org/obo/CHEBI_39237 |
T17 | 949-956 | Chemical | denotes | ligands | http://purl.obolibrary.org/obo/CHEBI_52214 |
T18 | 996-1005 | Chemical | denotes | farnesene | http://purl.obolibrary.org/obo/CHEBI_39237 |
T19 | 1013-1022 | Chemical | denotes | farnesene | http://purl.obolibrary.org/obo/CHEBI_39237 |
T20 | 1034-1042 | Chemical | denotes | farnesol | http://purl.obolibrary.org/obo/CHEBI_28600 |
T21 | 1050-1058 | Chemical | denotes | Farnesol | http://purl.obolibrary.org/obo/CHEBI_28600 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 303-318 | http://purl.obolibrary.org/obo/GO_0006605 | denotes | protein targets |
T2 | 603-614 | http://purl.obolibrary.org/obo/GO_0016791 | denotes | phosphatase |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-94 | Sentence | denotes | Essential Oils as Antiviral Agents, Potential of Essential Oils to Treat SARS-CoV-2 Infection: |
T2 | 95-121 | Sentence | denotes | An In-Silico Investigation |
T3 | 123-131 | Sentence | denotes | Abstract |
T4 | 132-221 | Sentence | denotes | Essential oils have shown promise as antiviral agents against several pathogenic viruses. |
T5 | 222-392 | Sentence | denotes | In this work we hypothesized that essential oil components may interact with key protein targets of the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). |
T6 | 393-809 | Sentence | denotes | A molecular docking analysis was carried out using 171 essential oil components with SARS-CoV-2 main protease (SARS-CoV-2 Mpro), SARS-CoV-2 endoribonucleoase (SARS-CoV-2 Nsp15/NendoU), SARS-CoV-2 ADP-ribose-1″-phosphatase (SARS-CoV-2 ADRP), SARS-CoV-2 RNA-dependent RNA polymerase (SARS-CoV-2 RdRp), the binding domain of the SARS-CoV-2 spike protein (SARS-CoV-2 rS), and human angiotensin−converting enzyme (hACE2). |
T7 | 810-931 | Sentence | denotes | The compound with the best normalized docking score to SARS-CoV-2 Mpro was the sesquiterpene hydrocarbon (E)-β-farnesene. |
T8 | 932-1113 | Sentence | denotes | The best docking ligands for SARS−CoV Nsp15/NendoU were (E,E)-α-farnesene, (E)-β-farnesene, and (E,E)−farnesol. (E,E)−Farnesol showed the most exothermic docking to SARS-CoV-2 ADRP. |